Home Food Allergies Advocacy and Analysis – October 2023

Advocacy and Analysis – October 2023


Study PEI’s latest allergist and the advocacy efforts behind it. Plus, be taught in regards to the newest on neffy®, an epinephrine nasal spray, and our ideas on the FDA resolution.

Advocacy: First allergist in PEI! 

We’re excited to share that Prince Edward Island can have its first allergist later this 12 months – Dr. Hannah Roberts.  

A number of years in the past, we advocated in PEI for elevated entry to correct medical take care of residents with meals allergy, and the hiring of an allergist and scientific immunologist. We enlisted the help of the members of our neighborhood in PEI who additionally reached out to the Well being Minister and their native MLAs. 

Because of the Islanders who helped help this initiative! Collectively, now we have helped to prioritize the necessity for allergy care, as residents had beforehand been travelling out-of-province to see an allergy specialist.  

Dr. Hannah Roberts 

Meet Dr. Hannah Roberts 

Dr. Roberts attended medical college on the College of Ottawa, adopted by a residency in Pediatrics at Memorial College. She accomplished a subspecialty fellowship in Allergy and Medical Immunology at BC Youngsters’s Hospital in Vancouver. Dr. Roberts holds board certification from the Royal School of Physicians and Surgeons of Canada in Pediatrics and Allergy & Medical Immunology. Previous to returning dwelling to Prince Edward Island to follow, she labored as an Allergist/Immunologist in Ontario and British Columbia.   

Advocacy and analysis: Newest growth with neffy® epinephrine nasal spray 

For these of you who’re following the developments within the U.S., the Meals and Drug Administration (FDA) has declined to approve neffy® epinephrine nasal spray beneath growth by ARS Prescription drugs, pending additional research. The corporate can have a chance to run further research and apply for approval once more. Learn their press launch.

Picture supply: ARS Prescription drugs

We’re disillusioned to be taught in regards to the FDA’s resolution to not approve the primary different to needle units. Nonetheless, we do help the rigor that’s required to make sure that these choices are secure and efficient for our neighborhood.

You may watch an interview with Dr. Edwin H. Kim, as he discusses the potential benefits and challenges of administering epinephrine intranasally versus an intramuscular injection, similar to with an epinephrine auto-injector.

Within the meantime, there are nonetheless two units obtainable in Canada which can be secure and efficient for the remedy of anaphylaxis and we encourage you to observe our quick video on the significance of epinephrine for the first-line remedy for anaphylaxis. This video illustrates why the immediate use of epinephrine is so essential.

We’ll proceed to observe this challenge and attain out to the consultants, and we’re dedicated to protecting you up to date on the progress.   

Hear & Study audio collection

Discover out extra about needle-free epinephrine for treating anaphylaxis.

Tags: advocacy, needle-free epinephrine, neffy, Analysis

Previous articleSuspected Bronchiectasis Tied to Greater Mortality, Even With out COPD
Next articleTexas Biomed Will get $500K to Pace Common Flu Shot Improvement